A single dose rifampin + ofloxacin + minocycline treatment has been recommended for: A. All cases of paucibacillary leprosy B. All relapse cases of paucibacillary leprosy C. Single skin lesion paucibacillary leprosy D. None of the above

A single dose rifampin + ofloxacin + minocycline
treatment has been recommended for:
A. All cases of paucibacillary leprosy
B. All relapse cases of paucibacillary leprosy
C. Single skin lesion paucibacillary leprosy
D. None of the above
by

1 Answer

Answer :

C. Single skin lesion paucibacillary leprosy
by

Related questions

If a multibacillary leprosy patient treated with standard fixed duration multidrug therapy relapses, he should be treated with: A. The same rifampin + dapsone + clofazimine regimen B. Clofazimine + ofloxacin + minocycline C. Clofazimine + ofloxacin + clarithromycin D. Ofloxacin + minocycline + clarithromycin

Description : If a multibacillary leprosy patient treated with standard fixed duration multidrug therapy relapses, he should be treated with: A. The same rifampin + dapsone + clofazimine regimen B. ... + minocycline C. Clofazimine + ofloxacin + clarithromycin D. Ofloxacin + minocycline + clarithromycin

Last Answer : . The same rifampin + dapsone + clofazimine regimen

The following is true of multidrug therapy of leprosy except: A. It has been highly successful in paucibacillary but not in multibacillary cases B. Relapse rate is very low in both paucibacillary and multibacillary cases C. No resistance to rifampin develops despite its use once a month D. Prevalence of lepra reaction is not higher compared to dapsone monotherapy

Description : The following is true of multidrug therapy of leprosy except: A. It has been highly successful in paucibacillary but not in multibacillary cases B. Relapse rate is very low in both paucibacillary ... use once a month D. Prevalence of lepra reaction is not higher compared to dapsone monotherapy

Last Answer : A. It has been highly successful in paucibacillary but not in multibacillary cases

Multidrug therapy with dapsone + rifampin ± clofazimine is the treatment of choice for: A. Multibacillary leprosy B. Paucibacillary leprosy C. Dapsone resistant leprosy D. All forms of leprosy

Description : Multidrug therapy with dapsone + rifampin ± clofazimine is the treatment of choice for: A. Multibacillary leprosy B. Paucibacillary leprosy C. Dapsone resistant leprosy D. All forms of leprosy

Last Answer : D. All forms of leprosy

Currently, monotherapy of leprosy with dapsone is recommended for: A. Paucibacillary leprosy only B. Multibacillary leprosy only C. Both paucibacillary and multibacillary leprosy D. Neither paucibacillary nor multibacillary leprosy

Description : Currently, monotherapy of leprosy with dapsone is recommended for: A. Paucibacillary leprosy only B. Multibacillary leprosy only C. Both paucibacillary and multibacillary leprosy D. Neither paucibacillary nor multibacillary leprosy

Last Answer : D. Neither paucibacillary nor multibacillary leprosy

Indicate the second line antitubercular drug that is being preferred to supplement ethambutol + streptomycin in case of hepatotoxicity due to isoniazid/ rifampin/pyrazinamide: A. Ethionamide B. Cycloserine C. Ofloxacin D. Capreomycin

Description : Indicate the second line antitubercular drug that is being preferred to supplement ethambutol + streptomycin in case of hepatotoxicity due to isoniazid/ rifampin/pyrazinamide: A. Ethionamide B. Cycloserine C. Ofloxacin D. Capreomycin

Last Answer : C. Ofloxacin

Which antileprotic drug suppresses lepra reaction and reversal reaction as well: A. Dapsone B. Rifampin C. Clofazimine D. Minocycline

Description : Which antileprotic drug suppresses lepra reaction and reversal reaction as well: A. Dapsone B. Rifampin C. Clofazimine D. Minocycline

Last Answer : C. Clofazimine

As per WHO guidelines, treatment of failure or relapse (category II) patients of smear positive pulmonary tuberculosis differs from that of new cases in the following respect(s): A. All 5 first line antitubercular drugs are given in the initial intensive phase B. Duration of intensive phase is increased to 5 months C. Three drugs (HRE) are given in the continuation phase instead of two (HR) D. Both 'A' and 'C'

Description : As per WHO guidelines, treatment of failure or relapse (category II) patients of smear positive pulmonary tuberculosis differs from that of new cases in the following respect(s): A. All 5 first line antitubercular drugs ... are given in the continuation phase instead of two (HR) D. Both 'A' and 'C'

Last Answer : D. Both 'A' and 'C'

Under the WHO guidelines for treatment of new cases of tuberculosis, when isoniazid + ethambutol are used in the continuation phase instead of isoniazid + rifampin,, the duration of this phase is: A. 2 months B. 4 months C. 6 months D. 8 month

Description : Under the WHO guidelines for treatment of new cases of tuberculosis, when isoniazid + ethambutol are used in the continuation phase instead of isoniazid + rifampin,, the duration of this phase is: A. 2 months B. 4 months C. 6 months D. 8 month

Last Answer : C. 6 months

A patient of vivax malaria was treated with the standard dose of chloroquine. After 6 weeks he reported back with a relapse. Which drug will you use to treat the relapse episode: A. Chloroquine B. Primaquine C. Pyrimethamine + sulfadoxine D. Mefloquin

Description : A patient of vivax malaria was treated with the standard dose of chloroquine. After 6 weeks he reported back with a relapse. Which drug will you use to treat the relapse episode: A. Chloroquine B. Primaquine C. Pyrimethamine + sulfadoxine D. Mefloquin

Last Answer : A. Chloroquine

Select the condition for which 3 days treatment with pyrantel pamoate is recommended in place of single dose therapy for others: A. Ascariasis B. Ancylostomiasis C. Necatoriasis D. Enterobiasis

Description : Select the condition for which 3 days treatment with pyrantel pamoate is recommended in place of single dose therapy for others: A. Ascariasis B. Ancylostomiasis C. Necatoriasis D. Enterobiasis

Last Answer : C. Necatoriasis

The distinctive feature of secnidazole is: A. It is not absorbed after oral ingestion B. It is recommended for single dose treatment of intestinal amoebiasis C. It is effective in intestinal but not in hepatic amoebiasis D. It is effective in both trichomonas as well as monilial vaginitis

Description : The distinctive feature of secnidazole is: A. It is not absorbed after oral ingestion B. It is recommended for single dose treatment of intestinal amoebiasis C. It is effective in intestinal but not in hepatic amoebiasis D. It is effective in both trichomonas as well as monilial vaginitis

Last Answer : B. It is recommended for single dose treatment of intestinal amoebiasis

Addition of pyrazinamide and ethambutol for the first two months to the isoniazid + rifampin therapy of tuberculosis serves the following purpose(s): A. Reduces the total duration of therapy to 6 months B. Produces more rapid sputum conversion C. Permits reduction of rifampin dose D. Both ‘A’ and ‘B’ are correct

Description : Addition of pyrazinamide and ethambutol for the first two months to the isoniazid + rifampin therapy of tuberculosis serves the following purpose(s): A. Reduces the total duration of therapy to 6 months B. ... sputum conversion C. Permits reduction of rifampin dose D. Both A' and B' are correct

Last Answer : D. Both ‘A’ and ‘B’ are correc

ifampin + pyrazinamide for initial 2 months followed by isoniazid + rifampin for another 4 months for the following category of tubercular patients: A. New sputum positive cases of pulmonary tuberculosis B. New sputum negative cases of pulmonary tuberculosis C. Sputum positive patients of pulmonary tuberculosis who have interrupted treatment for more than 2 months D. Tubercular meningitis patients

Description : ifampin + pyrazinamide for initial 2 months followed by isoniazid + rifampin for another 4 months for the following category of tubercular patients: A. New sputum positive cases of ... pulmonary tuberculosis who have interrupted treatment for more than 2 months D. Tubercular meningitis patients

Last Answer : B. New sputum negative cases of pulmonary tuberculosis

According to the current WHO guidelines, new (untreated) sputum smear positive cases of pulmonary tuberculosis are to be treated with the following regimen: A. Isoniazid + Rifampin + Pyrazinamide for 6 months B. Isoniazid + Thiacetazone + Rifampin for 2 months followed by isoniazid + thiacetazone for 6 months C. Isoniazid + Rifampin for 6 months with additional Pyrazinamide + Ethambutol/Streptomycin during the initial 2 months D. Isoniazid + Rifampin for 6 months with additional Pyrazinamide during the initial 2 months

Description : According to the current WHO guidelines, new (untreated) sputum smear positive cases of pulmonary tuberculosis are to be treated with the following regimen: A. Isoniazid + Rifampin + Pyrazinamide ... D. Isoniazid + Rifampin for 6 months with additional Pyrazinamide during the initial 2 months

Last Answer : C. Isoniazid + Rifampin for 6 months with additional Pyrazinamide + Ethambutol/Streptomycin during the initial 2 months

Currently, under the mass programme (WHO/NLEP), the duration of multidrug therapy for multibacillary leprosy is: A. Two years fixed duration for all cases B. One year fixed duration for all cases C. Two years or more till disease inactivity is attained D. One year for cases with bacillary index 3 or less and two years for cases with bacillary index 4 or more

Description : Currently, under the mass programme (WHO/NLEP), the duration of multidrug therapy for multibacillary leprosy is: A. Two years fixed duration for all cases B. One year fixed duration for all cases C. ... for cases with bacillary index 3 or less and two years for cases with bacillary index 4 or more

Last Answer : B. One year fixed duration for all cases

he multidrug therapy of leprosy is superior to monotherapy on the following account(s): A. It prevents emergence of dapsone resistance B. It is effective in cases with primary dapsone resistance C. It shortens the total duration of drug therapy and improves compliance D. All of the above

Description : he multidrug therapy of leprosy is superior to monotherapy on the following account(s): A. It prevents emergence of dapsone resistance B. It is effective in cases with primary dapsone resistance C. It shortens the total duration of drug therapy and improves compliance D. All of the above

Last Answer : D. All of the above

Occurrence of the following adverse reaction absolutely contraindicates further use of rifampin in the treatment of tuberculosis: A. Respiratory syndrome B. Cutaneous syndrome C. Flu syndrome D. Abdominal syndrome

Description : Occurrence of the following adverse reaction absolutely contraindicates further use of rifampin in the treatment of tuberculosis: A. Respiratory syndrome B. Cutaneous syndrome C. Flu syndrome D. Abdominal syndrome

Last Answer : A. Respiratory syndrome

The following is true of levamisole except: A. A single dose cures over 90% cases of round worm infestation B. It is more effective against Necator americanus than against Ancylostoma duodenale C. It has immunomodulating action D. Its prolonged use causes severe reactions

Description : The following is true of levamisole except: A. A single dose cures over 90% cases of round worm infestation B. It is more effective against Necator americanus than against Ancylostoma duodenale C. It has immunomodulating action D. Its prolonged use causes severe reactions

Last Answer : B. It is more effective against Necator americanus than against Ancylostoma duodenale

A single oral dose of the following drug can cure most cases of uncomplicated gonorrhoea: A. Ciprofloxacin B. Cotrimoxazole C. Spectinomycin D. Doxycycline

Description : A single oral dose of the following drug can cure most cases of uncomplicated gonorrhoea: A. Ciprofloxacin B. Cotrimoxazole C. Spectinomycin D. Doxycycline

Last Answer : A. Ciprofloxacin

Which fluoroquinolone is highly active against Mycobact. leprae and is being used in alternative multidrug therapy regimens: A. Norfloxacin B. Ofloxacin C. Ciprofloxacin D. Lomefloxacin

Description : Which fluoroquinolone is highly active against Mycobact. leprae and is being used in alternative multidrug therapy regimens: A. Norfloxacin B. Ofloxacin C. Ciprofloxacin D. Lomefloxacin

Last Answer : B. Ofloxacin

The following quinolone antimicrobial agent is not useful in systemic infections: A. Lomefloxacin B. Ofloxacin C. Nalidixic acid D. Pefloxacin

Description : The following quinolone antimicrobial agent is not useful in systemic infections: A. Lomefloxacin B. Ofloxacin C. Nalidixic acid D. Pefloxacin

Last Answer : C. Nalidixic acid

The tetracycline with highest antileprotic activity is: A. Minocycline B. Doxycycline C. Demeclocycline D. Oxytetracycline

Description : The tetracycline with highest antileprotic activity is: A. Minocycline B. Doxycycline C. Demeclocycline D. Oxytetracycline

Last Answer : A. Minocycline

The following tetracycline has the potential to cause vestibular toxicity: A. Minocycline B. Demeclocycline C. Doxycycline D. Tetracycline

Description : The following tetracycline has the potential to cause vestibular toxicity: A. Minocycline B. Demeclocycline C. Doxycycline D. Tetracycline

Last Answer : D. Tetracycline

Select the most potent tetracycline antibiotic: A. Demeclocycline B. Oxytetracycline C. Minocycline D. Doxycycline

Description : Select the most potent tetracycline antibiotic: A. Demeclocycline B. Oxytetracycline C. Minocycline D. Doxycycline

Last Answer : C. Minocycline

Combination therapy with two (or more) antimicrobials is superior to monotherapy with any single effective drug in case of the following diseases except: A. Typhoid fever B. Leprosy C. AIDS D. Subacute bacterial endocarditis

Description : Combination therapy with two (or more) antimicrobials is superior to monotherapy with any single effective drug in case of the following diseases except: A. Typhoid fever B. Leprosy C. AIDS D. Subacute bacterial endocarditis

Last Answer : A. Typhoid fever

For the treatment of Hymenolepis nana infestation, praziquantel has the following advantage(s) over niclosamide: A. It is better tolerated B. It requires single dose treatment against 5 days treatment with niclosamide C. A purgative is required after niclosamide but not after praziquantel D. All of the abov

Description : For the treatment of Hymenolepis nana infestation, praziquantel has the following advantage(s) over niclosamide: A. It is better tolerated B. It requires single dose treatment against 5 days treatment with ... C. A purgative is required after niclosamide but not after praziquantel D. All of the abov

Last Answer : B. It requires single dose treatment against 5 days treatment with niclosamide

The preferred regimen for preventing duodenal ulcer relapse is: A. Maintenance antacid regimen B. Maintenance H2 blocker regimen C. On demand intermittent H2 blocker regimen D. Maintenance sucralfate regimen

Description : The preferred regimen for preventing duodenal ulcer relapse is: A. Maintenance antacid regimen B. Maintenance H2 blocker regimen C. On demand intermittent H2 blocker regimen D. Maintenance sucralfate regimen

Last Answer : B. Maintenance H2 blocker regimen

Eradication of H.pylori along with gastric antisecretory drugs affords the following benefit(s): A. Faster relief of ulcer pain B. Faster ulcer healing C. Reduced chance of ulcer relapse D. Both ‘B’ and ‘C’ are correct

Description : Eradication of H.pylori along with gastric antisecretory drugs affords the following benefit(s): A. Faster relief of ulcer pain B. Faster ulcer healing C. Reduced chance of ulcer relapse D. Both ‘B’ and ‘C’ are correct

Last Answer : D. Both ‘B’ and ‘C’ are correct

In peptic ulcer, antacids are now primarily used for: A. Prompt pain relief B. Ulcer healing C. Preventing ulcer relapse D. Control of bleeding from the ulcer

Description : In peptic ulcer, antacids are now primarily used for: A. Prompt pain relief B. Ulcer healing C. Preventing ulcer relapse D. Control of bleeding from the ulcer

Last Answer : A. Prompt pain relief

The following statement is true about misoprostol: A. It relieves peptic ulcer pain, but does not promote ulcer healing B. It heals nonsteroidal antiinflammatory drug induced gastric ulcer not responding to H2 blockers C. It produces fewer side effects than H2 blockers D. It is the most effective drug for preventing ulcer relapse

Description : The following statement is true about misoprostol: A. It relieves peptic ulcer pain, but does not promote ulcer healing B. It heals nonsteroidal antiinflammatory drug induced gastric ulcer not responding ... side effects than H2 blockers D. It is the most effective drug for preventing ulcer relapse

Last Answer : B. It heals nonsteroidal antiinflammatory drug induced gastric ulcer not responding to H2 blockers

The following is true of simvastatin except: A. It is more potent than lovastatin B. At the highest recommended dose, it causes greater LDL-cholesterol lowering than lovastatin C. It does not undergo first pass metabolism in liver D. It can raise HDL-cholesterol level when the same is low at base line

Description : The following is true of simvastatin except: A. It is more potent than lovastatin B. At the highest recommended dose, it causes greater LDL-cholesterol lowering than lovastatin C. It does not undergo ... metabolism in liver D. It can raise HDL-cholesterol level when the same is low at base line

Last Answer : C. It does not undergo first pass metabolism in liver

A patient of chronic bronchial asthma maintained on oral prednisolone 20 mg daily and inhaled salbutamol as required develops chest infection. Which of the following measures is recommended: A. Stop prednisolone B. Reduce prednisolone dose to 5 mg/day C. No change/increase in prednisolone dose D. Substitute prednisolone with inhaled budesonid

Description : A patient of chronic bronchial asthma maintained on oral prednisolone 20 mg daily and inhaled salbutamol as required develops chest infection. Which of the following measures is recommended: A. ... mg/day C. No change/increase in prednisolone dose D. Substitute prednisolone with inhaled budesonid

Last Answer : C. No change/increase in prednisolone dose

Mycobact. tuberculosis infection in a HIV infected patient is treated with: A. The same antitubercular regimen as HIV negative patient B. Four first line antitubercular drugs for 2 months followed by a longer continuation phase of 7 months with rifampin + isoniazid C. All 5 first line antitubercular drugs for 9 months D. Clarithromycin + Ciprofloxacin + Rifabutin for 12 months

Description : Mycobact. tuberculosis infection in a HIV infected patient is treated with: A. The same antitubercular regimen as HIV negative patient B. Four first line antitubercular drugs for 2 months followed ... line antitubercular drugs for 9 months D. Clarithromycin + Ciprofloxacin + Rifabutin for 12 months

Last Answer : B. Four first line antitubercular drugs for 2 months followed by a longer continuation phase of 7 months with rifampin + isoniazid

Multidrug resistant (MDR) tuberculosis is defined as resistance to: A. Any two or more antitubercular drugs B. Isoniazid + any other antitubercular drug C. Isoniazid + Rifampin + any one or more antitubercular drugs D. All five first line antitubercular drugs

Description : Multidrug resistant (MDR) tuberculosis is defined as resistance to: A. Any two or more antitubercular drugs B. Isoniazid + any other antitubercular drug C. Isoniazid + Rifampin + any one or more antitubercular drugs D. All five first line antitubercular drugs

Last Answer : C. Isoniazid + Rifampin + any one or more antitubercular drugs

Which first line antitubercular drug is only tuberculostatic and not tuberculocidal: A. Rifampin B. Isoniazid C. Ethambutol D. Pyrazinamide

Description : Which first line antitubercular drug is only tuberculostatic and not tuberculocidal: A. Rifampin B. Isoniazid C. Ethambutol D. Pyrazinamide

Last Answer : C. Ethambutol

Rifampin kills tubercle bacilli by: A. Binding to mycobacterial DNA dependent RNA polymerase B. Inhibiting mycobacterial DNA synthesis C. Inhibiting synthesis of mycolic acids in mycobacteria D. Damaging mycobacterial mitochondria

Description : Rifampin kills tubercle bacilli by: A. Binding to mycobacterial DNA dependent RNA polymerase B. Inhibiting mycobacterial DNA synthesis C. Inhibiting synthesis of mycolic acids in mycobacteria D. Damaging mycobacterial mitochondria

Last Answer : A. Binding to mycobacterial DNA dependent RNA polymerase

Choose the correct statement about rifampin: A. It is the most active drug on slow growing tubercle bacilli B. Its antitubercular efficacy is lower than that of isoniazid C. It is active against many atypical mycobacteria D. It does not effectively cross blood-CSF barrier

Description : Choose the correct statement about rifampin: A. It is the most active drug on slow growing tubercle bacilli B. Its antitubercular efficacy is lower than that of isoniazid C. It is active against many atypical mycobacteria D. It does not effectively cross blood-CSF barrier

Last Answer : C. It is active against many atypical mycobacteria

The intermittently multiplying (spurter) tubercle bacilli present within caseous material having low oxygen tension are most susceptible to: A. Ethambutol B. Rifampin C. Streptomycin D. Pyrazinamide

Description : The intermittently multiplying (spurter) tubercle bacilli present within caseous material having low oxygen tension are most susceptible to: A. Ethambutol B. Rifampin C. Streptomycin D. Pyrazinamide

Last Answer : B. Rifampin

A patient of pulmonary tuberculosis treated with rifampin + isoniazid + pyrazinamide developed parasthesias, weakness, dizziness, ataxia and depressed tendon reflexes. Which of the following measures would you recommend: A. Temporarily discontinue isoniazid and add pyridoxine B. Substitute isoniazid with thiacetazone C. Substitute pyrazinamide with ethambutol D. Substitute rifampin with streptomycin

Description : A patient of pulmonary tuberculosis treated with rifampin + isoniazid + pyrazinamide developed parasthesias, weakness, dizziness, ataxia and depressed tendon reflexes. Which of the following ... with thiacetazone C. Substitute pyrazinamide with ethambutol D. Substitute rifampin with streptomycin

Last Answer : A. Temporarily discontinue isoniazid and add pyridoxine

Concurrent use of an aminoglycoside antibiotic should be avoided with the following antibiotic: A. Ampicillin B. Vancomycin C. Ciprofloxacin D. Rifampin

Description : Concurrent use of an aminoglycoside antibiotic should be avoided with the following antibiotic: A. Ampicillin B. Vancomycin C. Ciprofloxacin D. Rifampin

Last Answer : B. Vancomycin

In the multidrug therapy of leprosy, rifampicin is given: A. Daily B. On alternate days C. Weekly D. Monthly

Description : In the multidrug therapy of leprosy, rifampicin is given: A. Daily B. On alternate days C. Weekly D. Monthly

Last Answer : D. Monthly

Apart from its use in tuberculosis and leprosy, rifampin is a first line drug for the following infective disease: A. Toxoplasmosis B. Brucellosis C. Donovanosis D. Leishmaniasis

Description : Apart from its use in tuberculosis and leprosy, rifampin is a first line drug for the following infective disease: A. Toxoplasmosis B. Brucellosis C. Donovanosis D. Leishmaniasis

Last Answer : B. Brucellosis

In a patient with culture-positive enterococcal endocarditis who has failed to respond to vancomycin because of resistance, the treatment most likely to be effective is (a) Clarithromycin (b) Erythromycin (c) Linezolid (d) Minocycline (e) Ticarcillin

Description : In a patient with culture-positive enterococcal endocarditis who has failed to respond to vancomycin because of resistance, the treatment most likely to be effective is (a) Clarithromycin (b) Erythromycin (c) Linezolid (d) Minocycline (e) Ticarcillin

Last Answer : Ans: D

The total dose of chloroquine (base) for treatment of an episode of malarial fever in a nonimmune adult is: A. 1000 mg B. 1500 mg C. 2000 mg D. 2500 mg

Description : The total dose of chloroquine (base) for treatment of an episode of malarial fever in a nonimmune adult is: A. 1000 mg B. 1500 mg C. 2000 mg D. 2500 mg

Last Answer : B. 1500 mg

What is true of DOTS strategy for treatment of tuberculosis: A. It consists of an initial intensive phase and a later continuation phase B. The dose of antitubercular drugs is reduced after clinical response occurs C. The patient himself is made responsible for administering antitubercular drugs D. All of the above are correct

Description : What is true of DOTS strategy for treatment of tuberculosis: A. It consists of an initial intensive phase and a later continuation phase B. The dose of antitubercular drugs is reduced ... patient himself is made responsible for administering antitubercular drugs D. All of the above are correct

Last Answer : A. It consists of an initial intensive phase and a later continuation phase

Which of the following is not likely to be the cause of failure of antimicrobial therapy of an acute infection: A. Improper selection of drug and dose B. Acquisition of resistance during treatment C. Failure to drain the pus D. Uncontrolled diabetes mellitus

Description : Which of the following is not likely to be the cause of failure of antimicrobial therapy of an acute infection: A. Improper selection of drug and dose B. Acquisition of resistance during treatment C. Failure to drain the pus D. Uncontrolled diabetes mellitus

Last Answer : B. Acquisition of resistance during treatment

The regimens recommended for treatment of chloroquine resistant P.falciparum malaria in an adult include the following except: A. Quinine 10 mg/kg/8 hourly+ doxycycline 100 mg/day for 7 days B. Quinine 10 mg/kg 3 times a day × 7 days with pyrimethamine 75 mg + sulfadoxine 1500 mg on first day C. Mefloquine 0.5 g daily for 7 days D. Artemether 80 mg i.m./twice on first day followed by once daily for 4 days

Description : The regimens recommended for treatment of chloroquine resistant P.falciparum malaria in an adult include the following except: A. Quinine 10 mg/kg/8 hourly+ doxycycline 100 mg/day for 7 days B. Quinine 10 mg/kg ... 7 days D. Artemether 80 mg i.m./twice on first day followed by once daily for 4 days

Last Answer : C. Mefloquine 0.5 g daily for 7 days

Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin: A. Blocks the increased risk of myocardial infarction due to estrogen B. Blocks the increased risk of endometrial carcinoma due to estrogen C. Reverses vulval atrophy occurring in postmenopausal women D. Enhances the metabolic benefits of estrogen treatment

Description : Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin: A. Blocks the increased risk of myocardial ... vulval atrophy occurring in postmenopausal women D. Enhances the metabolic benefits of estrogen treatment

Last Answer : The estrogen commonly used for hormone replacement therapy in menopausal women is: A. Ethinylestradiol B. Estradiol benzoate C. Diethylstilbestrol D. Conjugated estrogens

Use of artemisinin derivatives is restricted to treatment of multidrug resistant falciparum malaria because: A. Wide spread use for all cases of malaria may foster development of resistant strains B. They are not active against P.vivax C. They are more toxic than quinine D. All of the above are correct

Description : Use of artemisinin derivatives is restricted to treatment of multidrug resistant falciparum malaria because: A. Wide spread use for all cases of malaria may foster development of resistant strains B. They are not ... P.vivax C. They are more toxic than quinine D. All of the above are correct

Last Answer : A. Wide spread use for all cases of malaria may foster development of resistant strain

ndicate the anti-HIV regimen that is generally reserved for advanced cases of AIDS or for repeated treatment failures: A. Two nucleoside reverse transcriptase inhibitors (NRTIs) + one protease inhibitor (PI) B. Three NRTIs C. Two NRTIs + one non-NRTI D. One NRTI + one non-NRTI + one PI

Description : ndicate the anti-HIV regimen that is generally reserved for advanced cases of AIDS or for repeated treatment failures: A. Two nucleoside reverse transcriptase inhibitors (NRTIs) + one protease inhibitor (PI) B. Three NRTIs C. Two NRTIs + one non-NRTI D. One NRTI + one non-NRTI + one PI

Last Answer : D. One NRTI + one non-NRTI + one PI